| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 4.10e-05 | 5 | 41 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 2.24e-04 | 11 | 41 | 2 | GO:0019103 | |
| GeneOntologyBiologicalProcess | mitochondrial NAD transmembrane transport | 3.86e-06 | 2 | 41 | 2 | GO:1990549 | |
| GeneOntologyBiologicalProcess | cellular response to hepatocyte growth factor stimulus | 6.91e-06 | 19 | 41 | 3 | GO:0035729 | |
| GeneOntologyBiologicalProcess | response to hepatocyte growth factor | 9.46e-06 | 21 | 41 | 3 | GO:0035728 | |
| GeneOntologyBiologicalProcess | NAD transmembrane transport | 3.84e-05 | 5 | 41 | 2 | GO:0035352 | |
| GeneOntologyBiologicalProcess | NAD transport | 5.75e-05 | 6 | 41 | 2 | GO:0043132 | |
| GeneOntologyBiologicalProcess | negative regulation of MHC class II biosynthetic process | 8.04e-05 | 7 | 41 | 2 | GO:0045347 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 9.04e-05 | 119 | 41 | 4 | GO:0010586 | |
| Domain | Bromodomain_CS | 1.41e-03 | 26 | 40 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 2.84e-03 | 37 | 40 | 2 | PS00633 | |
| Domain | Bromodomain | 2.99e-03 | 38 | 40 | 2 | PF00439 | |
| Domain | CYSTEINE_SWITCH | 3.48e-03 | 41 | 40 | 2 | PS00546 | |
| Domain | BROMODOMAIN_2 | 3.48e-03 | 41 | 40 | 2 | PS50014 | |
| Domain | BROMO | 3.65e-03 | 42 | 40 | 2 | SM00297 | |
| Domain | Bromodomain | 3.65e-03 | 42 | 40 | 2 | IPR001487 | |
| Domain | - | 3.65e-03 | 42 | 40 | 2 | 1.20.920.10 | |
| Domain | Pept_M10_metallopeptidase | 3.82e-03 | 43 | 40 | 2 | IPR001818 | |
| Domain | SOLCAR | 5.75e-03 | 53 | 40 | 2 | PS50920 | |
| Domain | - | 5.75e-03 | 53 | 40 | 2 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 5.75e-03 | 53 | 40 | 2 | IPR018108 | |
| Domain | Mito_carr | 5.75e-03 | 53 | 40 | 2 | PF00153 | |
| Domain | Mt_carrier_dom | 5.75e-03 | 53 | 40 | 2 | IPR023395 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 28607110 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 31226434 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32906142 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 18263767 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 30279688 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24451372 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 16800816 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 10878022 | ||
| Pubmed | The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions. | 4.06e-06 | 3 | 41 | 2 | 35932995 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 25486475 | ||
| Pubmed | Dual role of NRSF/REST in activation and repression of the glucocorticoid response. | 8.12e-06 | 4 | 41 | 2 | 17984088 | |
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 8.87e-06 | 34 | 41 | 3 | 30894540 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 11003650 | ||
| Pubmed | GATA3 acetylation at K119 by CBP inhibits cell migration and invasion in lung adenocarcinoma. | 1.35e-05 | 5 | 41 | 2 | 29453984 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 19448667 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.46e-05 | 40 | 41 | 3 | 34585037 | |
| Pubmed | An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. | 2.03e-05 | 6 | 41 | 2 | 11003653 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 10958685 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 26921097 | ||
| Pubmed | Stat3 dimerization regulated by reversible acetylation of a single lysine residue. | 2.03e-05 | 6 | 41 | 2 | 15653507 | |
| Pubmed | 2.11e-05 | 730 | 41 | 7 | 34857952 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 25329411 | ||
| Pubmed | A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression. | 2.84e-05 | 7 | 41 | 2 | 19081374 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 23671189 | ||
| Pubmed | Factors associated with the mammalian RNA polymerase II holoenzyme. | 2.84e-05 | 7 | 41 | 2 | 9443979 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 17043312 | ||
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 2.84e-05 | 7 | 41 | 2 | 21079652 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 18241676 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 2.84e-05 | 7 | 41 | 2 | 9590696 | |
| Pubmed | TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner. | 2.84e-05 | 7 | 41 | 2 | 20508149 | |
| Pubmed | Enhancer-mediated control of macrophage-specific arginase I expression. | 2.84e-05 | 7 | 41 | 2 | 15187136 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 23868976 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 18241125 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 21072211 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 6.07e-05 | 10 | 41 | 2 | 16751102 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 25223786 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 20388487 | ||
| Pubmed | Interplay between cell-adhesion molecules governs synaptic wiring of cone photoreceptors. | 6.07e-05 | 10 | 41 | 2 | 32879010 | |
| Pubmed | Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. | 6.07e-05 | 10 | 41 | 2 | 11238380 | |
| Pubmed | Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. | 6.07e-05 | 10 | 41 | 2 | 15619633 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 19061646 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 25314079 | ||
| Pubmed | 6.29e-05 | 359 | 41 | 5 | 35559673 | ||
| Pubmed | Generation and analysis of 280,000 human expressed sequence tags. | 7.07e-05 | 368 | 41 | 5 | 8889549 | |
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 28262416 | ||
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 7.41e-05 | 11 | 41 | 2 | 10204490 | |
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 18003620 | ||
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 15140983 | ||
| Pubmed | 9.68e-05 | 75 | 41 | 3 | 25593309 | ||
| Pubmed | Histone modifications defining active genes persist after transcriptional and mitotic inactivation. | 1.22e-04 | 14 | 41 | 2 | 15616580 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 1.41e-04 | 15 | 41 | 2 | 17255939 | |
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 11013263 | ||
| Pubmed | Cyclin B1/Cdk1 binds and phosphorylates Filamin A and regulates its ability to cross-link actin. | 1.61e-04 | 16 | 41 | 2 | 17408621 | |
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 11784859 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 8274451 | ||
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 14519686 | ||
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 19183483 | ||
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 14559996 | ||
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 16217013 | ||
| Pubmed | 2.20e-04 | 99 | 41 | 3 | 34161765 | ||
| Pubmed | 2.29e-04 | 19 | 41 | 2 | 16204234 | ||
| Pubmed | 2.41e-04 | 1442 | 41 | 8 | 35575683 | ||
| Pubmed | Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway. | 2.81e-04 | 21 | 41 | 2 | 20460684 | |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 3.25e-04 | 113 | 41 | 3 | 23403292 | |
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 21670149 | ||
| Pubmed | MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. | 3.38e-04 | 23 | 41 | 2 | 20332121 | |
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 14966270 | ||
| Pubmed | Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. | 3.60e-04 | 117 | 41 | 3 | 19124506 | |
| Pubmed | Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. | 3.68e-04 | 24 | 41 | 2 | 18454139 | |
| Pubmed | Chromatin regulation by Brg1 underlies heart muscle development and disease. | 4.00e-04 | 25 | 41 | 2 | 20596014 | |
| Pubmed | Endocardial Brg1 disruption illustrates the developmental origins of semilunar valve disease. | 4.00e-04 | 25 | 41 | 2 | 26100917 | |
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 5.03e-04 | 28 | 41 | 2 | 31600191 | |
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 5.03e-04 | 28 | 41 | 2 | 12192000 | |
| Pubmed | 6.04e-04 | 329 | 41 | 4 | 17474147 | ||
| Pubmed | 6.58e-04 | 32 | 41 | 2 | 23154389 | ||
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 6.58e-04 | 32 | 41 | 2 | 22424883 | |
| Pubmed | 7.43e-04 | 34 | 41 | 2 | 10857745 | ||
| Pubmed | 7.87e-04 | 35 | 41 | 2 | 22325351 | ||
| Pubmed | RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation. | 8.33e-04 | 36 | 41 | 2 | 17573780 | |
| Pubmed | 8.48e-04 | 157 | 41 | 3 | 30186101 | ||
| Pubmed | 8.80e-04 | 37 | 41 | 2 | 32912968 | ||
| Pubmed | 9.28e-04 | 38 | 41 | 2 | 29799838 | ||
| Pubmed | 9.28e-04 | 38 | 41 | 2 | 32541003 | ||
| Pubmed | Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse. | 9.28e-04 | 38 | 41 | 2 | 27930960 | |
| Pubmed | Systematic identification of NF90 target RNAs by iCLIP analysis. | 1.08e-03 | 41 | 41 | 2 | 35013429 | |
| Pubmed | 1.13e-03 | 42 | 41 | 2 | 35705031 | ||
| Pubmed | 1.13e-03 | 42 | 41 | 2 | 16387653 | ||
| Cytoband | 2q35 | 2.30e-03 | 79 | 41 | 2 | 2q35 | |
| Cytoband | Xp11.23 | 3.30e-03 | 95 | 41 | 2 | Xp11.23 | |
| Cytoband | 6q21 | 3.36e-03 | 96 | 41 | 2 | 6q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 5.20e-03 | 120 | 41 | 2 | chr17q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q21 | 5.28e-03 | 121 | 41 | 2 | chr6q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 5.98e-03 | 129 | 41 | 2 | chr2q35 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.62e-04 | 12 | 29 | 2 | 1243 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP | 1.88e-05 | 33 | 41 | 3 | M41050 | |
| Disease | palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement | 3.38e-05 | 7 | 38 | 2 | EFO_0800400 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 3.93e-05 | 51 | 38 | 3 | EFO_0022285 | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 8.82e-05 | 11 | 38 | 2 | OBA_2045176 | |
| Disease | prostate carcinoma | 1.25e-04 | 891 | 38 | 7 | EFO_0001663 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 1.25e-04 | 13 | 38 | 2 | OBA_2045174 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 1.68e-04 | 15 | 38 | 2 | OBA_2045067 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 2.17e-04 | 17 | 38 | 2 | OBA_2045173 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 2.72e-04 | 19 | 38 | 2 | EFO_0802076 | |
| Disease | Adenoid Cystic Carcinoma | 2.92e-04 | 100 | 38 | 3 | C0010606 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 4.02e-04 | 23 | 38 | 2 | OBA_2045181 | |
| Disease | sphingomyelin measurement | 4.42e-04 | 278 | 38 | 4 | EFO_0010118 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 5.15e-04 | 26 | 38 | 2 | OBA_2045194 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 5.15e-04 | 26 | 38 | 2 | OBA_2045191 | |
| Disease | Sezary Syndrome | 5.55e-04 | 27 | 38 | 2 | C0036920 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 7.58e-04 | 321 | 38 | 4 | EFO_0004612, EFO_0004639 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 8.47e-04 | 144 | 38 | 3 | EFO_0004611, EFO_0020943 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 8.83e-04 | 34 | 38 | 2 | DOID:9952 (is_marker_for) | |
| Disease | Non-Small Cell Lung Carcinoma | 1.07e-03 | 156 | 38 | 3 | C0007131 | |
| Disease | serum metabolite measurement | 1.22e-03 | 945 | 38 | 6 | EFO_0005653 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.28e-03 | 166 | 38 | 3 | EFO_0004530, EFO_0004611 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLYRVNINNSMPPGR | 1971 | Q92793 | |
| GKRNMYTAHPLPIGR | 86 | Q9HCK5 | |
| HLNNMAHYRPPALNL | 491 | Q96HY7 | |
| MNFRQLLLHLPRYLG | 1 | Q86YH6 | |
| PVGRHPYIMSRQLQY | 411 | P58397 | |
| QHGYIYPLRDPRSLM | 81 | O94810 | |
| APMSQVYGAPHLLRL | 291 | Q9UBU8 | |
| LLPPHRAQRYMDGHL | 1771 | O60840 | |
| HPLNYTILMRPRFGI | 141 | Q8NH92 | |
| THFPGNLPNMLRDLR | 31 | P22301 | |
| RWMQLGAFYPLPRNH | 621 | Q2M2H8 | |
| VHGERYMAVLRPLQP | 106 | Q8TDU6 | |
| RHNRVLDNYPMPIGH | 396 | P51511 | |
| MPVRRGHVAPQNTYL | 1 | Q9H252 | |
| GLMARRLYQPLPGSA | 221 | P51582 | |
| YHKMNGVNRPLVRPQ | 216 | Q9BWX5 | |
| LPGLPMNNHGNYIVR | 161 | Q16134 | |
| NEHLGFLYMIPAVPR | 196 | Q9C0G6 | |
| YPHPGTDNLLMLNGR | 276 | Q7Z5Q1 | |
| QHMDVGPAARAPYLL | 21 | O95886 | |
| PHTYCRLPRNLNPGM | 176 | O75064 | |
| PRPHLFGQMFVRLQL | 506 | Q5D0E6 | |
| AHRYMLAPDAPGRRQ | 1141 | Q02388 | |
| RLFENLRMLPHAPGV | 366 | Q92769 | |
| QPPRRNWLLGHLGMY | 61 | Q6NT55 | |
| APLSGPRRYQVMRQH | 371 | Q8ND04 | |
| ISYNRLHLVPRMGPS | 216 | Q8N1F8 | |
| MLLPGPLHSLQRAAY | 5466 | Q8WXH0 | |
| GFRNLYRGILPPLMQ | 76 | Q9H1U9 | |
| AYKMLARGQPLPDHL | 186 | P51532 | |
| NAKAGHPPALRRQYL | 41 | Q9H1Z4 | |
| GFRNLYRGILPPLMQ | 76 | Q3SY17 | |
| MRLARALGNHQPLPY | 171 | Q5SQS8 | |
| YRRNPLGDLMEHLVP | 251 | Q9UJT1 | |
| HQLANDPYLLPHMRR | 726 | Q9UKI8 | |
| LYILNHLMNPPNGKR | 261 | Q16851 | |
| YLNLRHNFMQLERPG | 276 | Q6ZVD8 | |
| MEQRNRLGALGYLPP | 1 | A6NLU5 | |
| AARLRPNYPAALMNL | 771 | Q8N394 | |
| PRRALYHNPPLSMGQ | 2146 | P31629 | |
| SELLLDRLHPNPMYQ | 541 | O15146 |